about
Imaging multiple sclerosis and other neurodegenerative diseasesThe thalamus and multiple sclerosis: modern views on pathologic, imaging, and clinical aspectsPrecision Medicine in Multiple Sclerosis: Future of PET Imaging of Inflammation and Reactive AstrocytesImaging Surrogates of Disease Activity in Neuromyelitis Optica Allow Distinction from Multiple SclerosisSensitivity and specificity of SWI venography for detection of cerebral venous alterations in multiple sclerosisTract-based spatial statistics analysis of diffusion-tensor imaging data in pediatric- and adult-onset multiple sclerosis.Rapid, high-resolution quantitative magnetization transfer MRI of the human spinal cord.Multiple sclerosis lesion geometry in quantitative susceptibility mapping (QSM) and phase imaging.Incorporating dixon multi-echo fat water separation for novel quantitative magnetization transfer of the human optic nerve in vivo.The Relationship Between Brain MR Spectroscopy and Disability in Multiple Sclerosis: 20-Year Data from the U.S. Glatiramer Acetate Extension Study.Feasibility and reproducibility of whole brain myelin water mapping in 4 minutes using fast acquisition with spiral trajectory and adiabatic T2prep (FAST-T2) at 3TCortical injury in multiple sclerosis; the role of the immune system.Quantitative susceptibility mapping of multiple sclerosis lesions at various ages.Assessing the correlation between grey and white matter damage with motor and cognitive impairment in multiple sclerosis patients.Susceptibility-weighted imaging provides insight into white matter damage in amyotrophic lateral sclerosis.The conundrum of iron in multiple sclerosis--time for an individualised approach.Improving the clinical correlation of multiple sclerosis black hole volume change by paired-scan analysis.Quantifying the local tissue volume and composition in individual brains with magnetic resonance imagingComparison of Diffuse Weighted Imaging and Fluid Attenuation Inversion Recovery Sequences of MRI in Brain Multiple Sclerosis Plaques Detection.Arterial, venous and other vascular risk factors in multiple sclerosis.Interleukin-13 immune gene therapy prevents CNS inflammation and demyelination via alternative activation of microglia and macrophages.Diffusion Tensor Imaging in NAWM and NADGM in MS and CIS: Association with Candidate Biomarkers in SeraAdvances in understanding gray matter pathology in multiple sclerosis: are we ready to redefine disease pathogenesis?Normalization of white matter intensity on T1-weighted images of patients with acquired central nervous system demyelination.Contrast enrichment of spinal cord MR imaging using a ratio of T1-weighted and T2-weighted signals.No regional gray matter atrophy differences between pediatric- and adult-onset relapsing-remitting multiple sclerosis.Subcortical and cortical gray matter atrophy in a large sample of patients with clinically isolated syndrome and early relapsing-remitting multiple sclerosis.Proton MR spectroscopy of lesion evolution in multiple sclerosis: Steady-state metabolism and its relationship to conventional imaging.7T MRI-Histologic Correlation Study of Low Specific Absorption Rate T2-Weighted GRASE Sequences in the Detection of White Matter Involvement in Multiple Sclerosis.Cervical spinal cord volume loss is related to clinical disability progression in multiple sclerosis.Phase white matter signal abnormalities in patients with clinically isolated syndrome and other neurologic disorders.In vivo evidence of oxidative stress in brains of patients with progressive multiple sclerosis.
P2860
Q26826889-82094C99-B912-45C4-A0AA-1D69DF44B86EQ26851476-3BBD9A26-790E-4A58-AA3A-F81562FC1CE3Q28078621-A6BEEFED-C7B1-4FC8-AB9E-F1003213CB9BQ28267527-D52EAE77-42C9-4BB1-80B8-FEC0D01B3157Q28269079-41A339F6-B98A-4F49-AFBE-87F95EBA397FQ30560177-8CA5A4E9-252F-4845-A319-6612AA590E9DQ30778759-924953E3-3256-4A99-B785-66FCB3339765Q30846734-E55237B3-C567-4C72-895C-5ACE4374EC1BQ31066868-54C3EAAC-27B2-4405-B6F5-8E5FB6F4033BQ31100010-78443ECA-FB36-451D-80A1-43C5737C0DA1Q33842099-7DB3647D-249E-4527-97EB-595D79B2A2F4Q34092684-B295DBA3-898F-4CCF-83DB-B1BF4426FBBCQ34681059-A65FE867-3A0A-4418-A490-D0DA23C24126Q34733726-A609B903-957B-4989-A50E-69C6508EC3B6Q35673939-1FE52828-E203-4765-803E-17D9C49998D3Q36110218-E314A750-81D3-4212-91B0-532A0AC29A7EQ37133611-C7EF1158-98D4-4239-9275-1E23E7D53E20Q37374973-533AD12D-B591-47C7-A4DA-FE4C5FA5AF58Q37670974-9C0FDBAA-5720-4BC4-BE00-E65EF3BA35AAQ38042766-8E502F27-353D-45A5-BE41-9D66BD1BAE07Q40499853-8A408781-3931-4B74-AB35-9CA1045A3C7AQ41771263-224422BA-14D1-4555-98F2-3B3158455909Q42564134-A8FD3FE8-D3F5-4245-A57A-3A313646E8A5Q43641658-46DA1125-830C-4316-9753-76422CAA6660Q44790503-517DCD7D-E710-4A73-91F8-9EBB61ADB5B2Q44903815-B634C575-5683-494E-BB0F-4DAB251C364CQ47908989-CA4207A7-42C3-4D38-BE74-46BBCDFFFD3BQ48122818-11848217-A793-4843-9EE5-5F111975AEA5Q48217899-ED798625-294B-4BC4-B61E-B0B7968D6BC5Q48690785-27ADCB34-5CCC-4A1D-A2C0-9C0943B9C051Q48756866-2CBB796C-CE91-485D-8C55-9FD164FAA708Q52092957-3E8179F2-D1A5-44BB-810B-D8F4C5B00513
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Recent developments in imaging of multiple sclerosis.
@ast
Recent developments in imaging of multiple sclerosis.
@en
type
label
Recent developments in imaging of multiple sclerosis.
@ast
Recent developments in imaging of multiple sclerosis.
@en
prefLabel
Recent developments in imaging of multiple sclerosis.
@ast
Recent developments in imaging of multiple sclerosis.
@en
P2093
P1433
P1476
Recent developments in imaging of multiple sclerosis.
@en
P2093
Alireza Minagar
E Mark Haacke
Guy Poloni
P304
P356
10.1097/NRL.0B013E31821A2643
P407
P577
2011-07-01T00:00:00Z